Literature DB >> 22389332

Cost effectiveness of interventions to tackle non-communicable diseases.

Paul Revill, Mark Sculpher.   

Abstract

Mesh：

Year:  2012        PMID： 22389332     DOI： 10.1136/bmj.d7883

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Management of NCD in low- and middle-income countries.

Authors:  William Checkley; Hassen Ghannem; Vilma Irazola; Sylvester Kimaiyo; Naomi S Levitt; J Jaime Miranda; Louis Niessen; Dorairaj Prabhakaran; Cristina Rabadán-Diehl; Manuel Ramirez-Zea; Adolfo Rubinstein; Alben Sigamani; Richard Smith; Nikhil Tandon; Yangfeng Wu; Denis Xavier; Lijing L Yan
Journal:  Glob Heart       Date:  2014-12

2.  How to dampen the surge of non-communicable diseases in Southeast Asia: insights from a systematic review and meta-analysis.

Authors:  Manuela Fritz; Hanna Fromell
Journal:  Health Policy Plan       Date:  2022-01-13       Impact factor: 3.344

3.  Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysis.

Authors:  Andrew N Phillips; Valentina Cambiano; Alec Miners; Paul Revill; Deenan Pillay; Jens D Lundgren; Diane Bennett; Elliott Raizes; Fumiyo Nakagawa; Andrea De Luca; Marco Vitoria; Jhoney Barcarolo; Joseph Perriens; Michael R Jordan; Silvia Bertagnolio
Journal:  Lancet HIV       Date:  2014-10-14       Impact factor: 12.767

4.  Growing Burden of Non-Communicable Diseases in the Emerging Health Markets: The Case of BRICS.

Authors:  Mihajlo B Jakovljevic; Olivera Milovanovic
Journal:  Front Public Health       Date:  2015-04-23

5.  Opportunities for improving the efficiency of paediatric HIV treatment programmes.

Authors:  Paul A Revill; Simon Walker; Travor Mabugu; Kusum J Nathoo; Peter Mugyenyi; Adeodata Kekitinwa; Paula Munderi; Mutsawashe Bwakura-Dangarembizi; Victor Musiime; Sabrina Bakeera-Kitaka; Patricia Nahirya-Ntege; A Sarah Walker; Mark J Sculpher; Diana M Gibb
Journal:  AIDS       Date:  2015-01-14       Impact factor: 4.177
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.